Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies.

This article discusses and focuses on using MDM4 as a novel biomarker as well as a therapeutic target for hematologic malignancies.
PMID: 26567881 [PubMed - in process]

Source: Current Cancer Drug Targets - November 18, 2015 Category: Cancer & Oncology Authors: Cao L, Fan L, Xu W, Li JY Tags: Curr Cancer Drug Targets Source Type: research